These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2084931)

  • 1. [Efficacy of myelopid in immunodeficiency states].
    Petrov RV; Borisova AM; Glazko AV; Simonova AV; Stepanenko RN
    Ter Arkh; 1990; 62(12):81-7. PubMed ID: 2084931
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current approaches to the prevention of infectious complications in heart surgery].
    Bogomolova NS; Abbakumov VV; Stepanenko RN; Potekhina AD; Pkhakadze TIa; Vinogradova LN
    Khirurgiia (Mosk); 1993 Feb; (2):46-53. PubMed ID: 8084151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of clinico-immunological testing of myelopid in chronic forms of multiple sclerosis].
    Gusev EI; Demina TL; Boĭko AN; Popova NF; Stepanenko RN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(2):18-25. PubMed ID: 1326165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of immunocompetent cell subpopulations in chronic bronchitis patients during the use of different immunomodulating preparations].
    Karaulov AV; Sil'vestrov VP; Martsinovskiĭ VIu; Bulycheva NA; Likov VF
    Ter Arkh; 1984; 56(10):14-7. PubMed ID: 6335305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of immunotropic preparations in chronic bronchitis].
    Sil'vestrov VP; Karaulov AV; Martsinovskiĭ VIu; Semin SN; Ogarkov VI
    Ter Arkh; 1988; 60(3):42-5. PubMed ID: 2968678
    [No Abstract]   [Full Text] [Related]  

  • 6. [Secondary immunodeficiency and its myelopid correction in patients with infiltrative and disseminated pulmonary tuberculosis].
    Averchenkov VM; Lomachenkov VD; Fedotova NI; Meshkova RIa
    Probl Tuberk; 1998; (2):20-2. PubMed ID: 9613178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunomodulating therapy with myelopid in experimental Salmonella infection].
    Osmanova LIa; Gurariĭ NI
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Aug; (8):94-7. PubMed ID: 2686306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Various aspects of the status of humoral immunity in patients after surgical correction of rheumatic heart defects under artificial circulation].
    Abbakumov VV; Bogomolova NS; Stepanenko RN; Ivanov VA; Potekhina AD; Vlasenko RIa; Sorokina VI
    Vestn Akad Med Nauk SSSR; 1990; (10):17-20. PubMed ID: 2278176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of individual sensitivity to levamisole in children with asthmatic bronchitis].
    Askambaeva KA; Shafranova NG
    Sov Med; 1990; (10):29-31. PubMed ID: 2293384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of thymus gland peptides in chronic cholecystitis].
    Rodoman GV; Belousov IuB; Kostrova MV; Petrov OA
    Sov Med; 1991; (3):73-4. PubMed ID: 1882302
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes of immune and non-specific reactivity in patients with chronic suppurative obstructive bronchitis in comprehensive treatment with thymogen].
    Litvinova NV; Eremeev VV; Abramova ZP; Kulikovskaia NV; Gergert VIa
    Probl Tuberk; 1994; (4):48-50. PubMed ID: 7984617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of myelopid in the complex treatment of patients with destructive pulmonary tuberculosis].
    Vakhidova GA; Vasil'eva FR; Kurbanova RR; Stepanenko RN; Ubaĭdullaev AM
    Probl Tuberk; 1990; (3):16-8. PubMed ID: 2367502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of chlotazol as an immunomodulating agent in chronic bronchitis].
    Kleĭner AI; Shmuter LM; Makotchenko VM; Efremova VA; Khodzhaĭ IaI; Trukh VS
    Klin Med (Mosk); 1991 Apr; 69(4):58-60. PubMed ID: 1865653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology].
    Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Arion VIa; Eletskiĭ AIu
    Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment with thymogen and myelopid of patients with bronchial asthma].
    Zoloedov VI; Zemskov AM; Stupnitskiĭ AA; Goriainova TA
    Klin Med (Mosk); 1995; 73(6):43-5. PubMed ID: 8691781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possibilities of immunotherapy in chronic pancreatitis].
    Gubergrits NB; Gubergrits EA
    Sov Med; 1991; (4):52-4. PubMed ID: 1871631
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of myelopid in the combined treatment of infectious-inflammatory complications in the postoperative period in neuro-oncology patients].
    Lisianyĭ NI; Romodanov SA; Radzievskiĭ AA; Rudenko VA; Pedachenko EG
    Zh Vopr Neirokhir Im N N Burdenko; 1991; (3):16-8. PubMed ID: 1661534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-immunological evaluation of using T-activin in children with obstructive bronchitis (data of immediate and late studies)].
    Eiubova AA; Budagov FG; Rzakulieva DM
    Pediatriia; 1991; (1):108. PubMed ID: 2041682
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinico-immunologic parallels in evaluating the treatment of multiple sclerosis].
    Chernigovskaia NV; Ogurtsov RP; Matveeva TS; Popov VG; Puzyreva VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):24-8. PubMed ID: 2160163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and immunological studies in borderline mental disorders: problems and solutions].
    Aleksandrovskiĭ IuA; Chekhonin VP
    Vestn Ross Akad Med Nauk; 1999; (7):12-5. PubMed ID: 10467878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.